StockNews.com cut shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a strong-buy rating to a buy rating in a research note published on Thursday morning.
Several other analysts also recently commented on the company. B. Riley started coverage on Tactile Systems Technology in a research note on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price for the company. Oppenheimer lowered Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th.
Check Out Our Latest Stock Analysis on Tactile Systems Technology
Tactile Systems Technology Stock Down 0.2 %
Institutional Trading of Tactile Systems Technology
Institutional investors and hedge funds have recently modified their holdings of the stock. SG Americas Securities LLC grew its holdings in Tactile Systems Technology by 12.7% during the fourth quarter. SG Americas Securities LLC now owns 12,032 shares of the company’s stock worth $206,000 after buying an additional 1,354 shares in the last quarter. Arcadia Investment Management Corp MI bought a new stake in shares of Tactile Systems Technology in the 3rd quarter worth $29,000. Gladius Capital Management LP purchased a new stake in shares of Tactile Systems Technology in the third quarter valued at about $44,000. Quarry LP bought a new position in shares of Tactile Systems Technology during the second quarter valued at about $46,000. Finally, Rhumbline Advisers boosted its holdings in Tactile Systems Technology by 11.6% during the second quarter. Rhumbline Advisers now owns 39,318 shares of the company’s stock worth $469,000 after purchasing an additional 4,099 shares during the last quarter. 83.43% of the stock is owned by hedge funds and other institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Read More
- Five stocks we like better than Tactile Systems Technology
- What is the Shanghai Stock Exchange Composite Index?
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- 3 Healthcare Dividend Stocks to Buy
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Earnings Per Share Calculator: How to Calculate EPS
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.